Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Oragenics Inc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −1 vs. Q2 2025
- Shares held
- 122.5K
- +87.9K (+253.6%) vs. Q2 2025
- Total value
- $160.5K
- +$28.7K (+21.8%) vs. Q2 2025
- New holders
- 4
- 1 more added
- Sold out
- 5
- 4 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $39.2K |
| Q1 2026 | 20 | $105.8K |
| Q4 2025 | 19 | $169.3K |
| Q3 2025 | 16 | $160.5K |
| Q2 2025 | 18 | $401.6K |
| Q1 2025 | 22 | $57.2K |
| Q4 2024 | 24 | $86.0K |
| Q3 2024 | 16 | $62.2K |
| Q2 2024 | 16 | $135.6K |
| Q1 2024 | 14 | $269.2K |
| Q4 2023 | 15 | $349.5K |
| Q3 2023 | 13 | $182.1K |
| Q2 2023 | 13 | $173.5K |
| Q1 2023 | 14 | $192.4K |
| Q4 2022 | 31 | $1.08M |
| Q3 2022 | 29 | $2.48M |
| Q2 2022 | 29 | $3.06M |
| Q1 2022 | 28 | $3.62M |
| Q4 2021 | 33 | $4.96M |
| Q3 2021 | 29 | $6.82M |
| Q2 2021 | 22 | $6.63M |
| Q1 2021 | 29 | $8.27M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Oragenics Inc; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DRW Securities, LLC | 61,809 | $81.0K | 0.00% | +61,809 | New |
| Sabby Management, LLC | 58,953 | $77.2K | 0.40% | +58,953 | New |
| BlackRock, Inc. | 703 | $921 | 0.00% | +2+0.3% | Added |
| Allworth Financial LP | 334 | $438 | 0.00% | +334 | New |
| UBS Group AG | 271 | $355 | 0.00% | −1,621−85.7% | Reduced |
| Tower Research Capital LLC (TRC) | 208 | $272 | 0.00% | −457−68.7% | Reduced |
| Morgan Stanley | 138 | $181 | 0.00% | −11,774−98.8% | Reduced |
| Bank of America Corp | 36 | $47 | 0.00% | −15,510−99.8% | Reduced |
| Wells Fargo & Company | 34 | $45 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 34 | $45 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 10 | $13 | 0.00% | 00.0% | Unchanged |
| Evermay Wealth Management LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Strategic Wealth Partners, Ltd. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Chesapeake Asset Management LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 1 | $1 | 0.00% | +1 | New |
| Royal Bank of Canada | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −681−100.0% | Sold out |
| Lionsbridge Wealth Management LLC | 0 | $0 | 0.00% | −667−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Clear Street LLC | – | – | – | – | Not filed |